文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

乳酸联合SOFA评分提高重症中暑患者SOFA评分预测效能

Lactate combined with SOFA score for improving the predictive efficacy of SOFA score in patients with severe heatstroke.
PubMed 文献 · Am J Emerg Med · 2024-01-23
一句话结论多中心回顾性队列显示,乳酸是重症中暑死亡及AKI、DIC、心肌损伤的独立危险因素,乳酸联合SOFA评分预测死亡的AUC(0.9025)优于单用SOFA评分(0.8773)。

该多中心回顾性队列纳入275例重症中暑患者,采用逻辑回归分析乳酸与患者结局及并发症(急性肾损伤、弥散性血管内凝血、心肌损伤)的关系,并用ROC曲线和临床决策曲线分析评估乳酸及SOFA评分对重症中暑相关死亡的预测效能,Kaplan-Meier生存曲线区分不同组间生存率。调整混杂因素后,乳酸是死亡(OR=1.353,95%CI[1.170,1.569])、AKI(OR=1.158,95%CI[1.007,1.332])、DIC(OR=1.426,95%CI[1.225,1.659])、心肌损伤(OR=2.039,95%CI[1.553,2.679])的独立危险因素,乳酸预测死亡的AUC为0.7540,截断值3.35。乳酸联合SOFA评分预测死亡的AUC为0.9025,优于单用SOFA评分的0.8773(DeLong检验,P<0.001),且DCA显示联合方案净临床获益率更高。

要点

  • 调整混杂因素后,乳酸是重症中暑死亡的独立危险因素(OR=1.353,95%CI[1.170,1.569])。
  • 乳酸预测重症中暑死亡的AUC为0.7540,截断值为3.35。
  • 乳酸联合SOFA评分预测重症中暑死亡的AUC为0.9025,优于单用SOFA评分的0.8773(DeLong检验,P<0.001)。
  • 乳酸升高患者死亡率更高(Kaplan-Meier生存曲线分析)。
  • 乳酸联合SOFA评分的DCA净临床获益率高于单用SOFA评分。

适用人群与场景

  • 275例重症中暑患者,多中心回顾性队列研究。

诊断标准与关键阈值

  • 乳酸预测重症中暑死亡的截断值为3.35。

研究设计与关键结果

  • 研究类型为多中心回顾性队列,纳入275例患者。
  • 调整混杂因素后,乳酸是死亡的独立危险因素(OR=1.353,95%CI[1.170,1.569])。
  • 乳酸是AKI的独立危险因素(OR=1.158,95%CI[1.007,1.332])。
  • 乳酸是DIC的独立危险因素(OR=1.426,95%CI[1.225,1.659])。
  • 乳酸是心肌损伤的独立危险因素(OR=2.039,95%CI[1.553,2.679])。
  • 乳酸预测死亡的AUC为0.7540,截断值3.35。
  • Kaplan-Meier生存曲线显示乳酸升高患者死亡率更高。
  • 乳酸联合SOFA评分预测死亡的AUC为0.9025,单用SOFA评分为0.8773(DeLong检验,P<0.001)。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,乳酸联合SOFA评分可显著提高对重症中暑患者的预测效能。
  • 原文未据此给出其他推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The relationship between lactate levels and multiple organ dysfunction in patients with severe heatstroke remains unclear. In this study, we aimed to elucidate the clinical significance of lactate in severe heatstroke prognosis and assess whether incorporating lactate in the SOFA score improves its predictive efficacy.

METHODS: This study was a multicenter retrospective cohort investigation included 275 patients. Logistic regression analysis was performed to examine the relationship between lactate levels and patient outcomes and complications, including acute kidney injury (AKI), disseminated intravascular coagulation (DIC), and myocardial injury. Further, receiver operating characteristic (ROC) curves and clinical decision curve analysis (DCA) were used to evaluate the predictive power of lactate and SOFA scores in severe heatstroke-associated death. Lastly, the Kaplan-Meier survival curve was employed to differentiate the survival rates among the various patient groups.

RESULTS: After adjusting for confounding factors, lactate was demonstrated as an independent risk factor for death (OR = 1.353, 95% CI [1.170, 1.569]), AKI (OR = 1.158, 95% CI [1.007, 1.332]), DIC (OR = 1.426, 95% CI [1.225, 1.659]), and myocardial injury (OR = 2.039, 95% CI [1.553, 2.679]). The area under the curve (AUC) of lactate for predicting death from severe heatstroke was 0.7540, with a cutoff of 3.35. The Kaplan-Meier survival curve analysis showed that patients with elevated lactate levels had higher mortality rates. Additionally, the ROC curves demonstrated that combining lactate with the SOFA score provided better predictive efficacy than the SOFA score alone in patients with severe heatstroke (AUC: 0.9025 vs. 0.8773, DeLong test, P < 0.001). Finally, the DCA curve revealed a higher net clinical benefit rate for lactate combined with the SOFA score.

CONCLUSIONS: Lactate is an independent risk factor for severe heatstroke-related death as well as a risk factor for AKI, DIC, and myocardial injury associated with severe heatstroke. Thus, combining lactate with the SOFA score can significantly improve its predictive efficacy in patients with severe heatstroke.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Liu F, Jin F, Zhang L, et al. Lactate combined with SOFA score for improving the predictive efficacy of SOFA score in patients with severe heatstroke. Am J Emerg Med. 2024. PMID: 38295465. doi:10.1016/j.ajem.2024.01.033

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。